The feasibility and reliability of transient elastography using Fibroscan®: A practice audit of 2335 examinations

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 3, 2014, Pages 143-149

  Pang, Jack X Q ^a   Pradhan, Faruq ^a   Zimmer, Scott ^b   Niu, Sophia ^b   Crotty, Pam ^a   Tracey, Jenna ^a   Schneider, Christopher ^a   Heitman, Steven J ^a   Kaplan, Gilaad G ^a   Swain, Mark G ^a   Myers, Robert P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Biopsy; Diagnostic test; Fibrosis; Hepatitis; Stiffness

Indexed keywords

ADULT; AGE; ALCOHOL ABUSE; ARTICLE; AUTOIMMUNE LIVER DISEASE; BLOOD CLOTTING DISORDER; BODY MASS; CHRONIC LIVER DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ELASTOGRAPH; ELASTOGRAPHY; ELECTROLYTE DISTURBANCE; FEASIBILITY STUDY; FEMALE; GENDER; HEART ARRHYTHMIA; HEPATITIS B; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONALCOHOLIC FATTY LIVER; OBESITY; PARALYSIS; PEPTIC ULCER; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; TRANSIENT ELASTOGRAPHY; DEVICES; ECHOGRAPHY; EVALUATION STUDY; MEDICAL AUDIT; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; COMORBIDITY; ELASTICITY IMAGING TECHNIQUES; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MEDICAL AUDIT; MIDDLE AGED; OBESITY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84899765161     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/952684     Document Type: Article

References (42)

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009;49:1017-44.
2. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-8.
3. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-906. (Pubitemid 40824701)
4. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int 2008;28:705-12. (Pubitemid 351541104)
5. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13. (Pubitemid 38091720)
6. Myers RP, Elkashab M, Ma M, Crotty P, Pomier-Layrargues G. Transient elastography for the noninvasive assessment of liver fibrosis: A multicentre Canadian study. Can J Gastroenterol 2010;24:661-70.
7. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208.
8. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835-47.
9. Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-analysis. Gastroenterology 2008;134:960-74.
10. Steadman R, Myers RP, Leggett L, et al. A health technology assessment of transient elastography in adult liver disease. Can J Gastroenterol 2013;27:149-58.
11. Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-9.
12. Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal NH. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat 2012;19:e184-e193.
13. Merchante N, Rivero-Juarez A, Tellez F, et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology 2012;56:228-38.
14. Robic MA, Procopet B, Metivier S, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. J Hepatol 2011;55:1017-24.
15. Kim SU, Lee JH, Kim do Y, et al. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012;7:e36676.
16. Masuzaki R, Tateishi R, Yoshida H, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009;49:1954-61.
17. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011;53:885-94.
18. Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 2010;51:828-35.
19. Boursier J, Zarski JP, de Ledinghen V, et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 2013;57:1182-91.
20. Myers RP, Liu M, Shaheen AA. The burden of hepatitis C virus infection is growing: A Canadian population-based study of hospitalizations from 1994 to 2004. Can J Gastroenterol 2008;22:381-7. (Pubitemid 351772332)
21. Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol 2004;2:1032-8. (Pubitemid 39539754)
22. Myers RP, Shaheen AA, Fong A, et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study. Hepatology 2009;50:1884-92.
23. Myers RP, Shaheen AA, Li B, Dean S, Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 2008;6:918-25.
24. Myers RP, Leung Y, Shaheen AA, Li B. Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res 2007;7:159.
25. Quan H, Parsons GA, Ghali WA. Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol 2004;57:366-72. (Pubitemid 38609275)
26. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002;40:675-85.
27. Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care 2004;42:801-9.
28. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. (Pubitemid 41587600)
29. Data Disclosure Handbook. In: Alberta Health and Wellness; 2003:1-15.
30. Williams JI, Young W. A summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, Blackstein-Hirsch P, Fooks C, Naylor CD, eds. Patterns of Health Care in Ontario: The ICES Practice Atlas, 2nd edn. Ottawa: The Canadian Medical Association, 1996:339-345.
31. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50. (Pubitemid 40439195)
32. International Classificiation of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Los Angeles: Practice Management Information Corporation, 2001.
33. WHO. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) Geneva: World Health Organization, 1992.
34. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27. (Pubitemid 128456396)
35. Myers RP, Quan H, Hubbard JN, Shaheen AA, Kaplan GG. Predicting in-hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods. Hepatology 2009;49:568-77.
36. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 2008;8:12.
37. Sprung J, Gajic O, Warner DO. Review article: Age related alterations in respiratory function - anesthetic considerations. Can J Anaesth 2006;53:1244-57.
38. Witters P, De Boeck K, Dupont L, et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros 2009;8:392-9.
39. Lucidarme D, Foucher J, Le Bail B, et al. Factors of accuracy of transient elastography (Fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083-9.
40. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010;30:1471-80.
41. Pradhan F, Ladak F, Tracey J, Crotty P, Myers RP. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol 2013;12:100-7.
42. Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206-10.